Figure 3From: Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence a: Kaplan-Meier estimate of the probability of continuing pharmacological treatment for patients who started treatment between 13 and 17 years (n=397). b: Kaplan-Meier estimate of the probability of continuing pharmacological treatment for male and female patients who started treatment between 13 and 17 years (n=397).Back to article page